38628797|t|Novel Isoxazolidines as RIPK1 Inhibitors for Treating Alzheimer's Disease, Multiple Sclerosis, and Amyotrophic Lateral Sclerosis.
38628797|a|Provided herein are novel isoxazolidines as RIPK1 inhibitors, pharmaceutical compositions, use of such compounds in treating Alzheimer's disease, multiple sclerosis, and amyotrophic lateral sclerosis (ALS), and processes for preparing such compounds.
38628797	6	20	Isoxazolidines	Chemical	-
38628797	24	29	RIPK1	Gene	8737
38628797	54	73	Alzheimer's Disease	Disease	MESH:D000544
38628797	75	93	Multiple Sclerosis	Disease	MESH:D009103
38628797	99	128	Amyotrophic Lateral Sclerosis	Disease	MESH:D000690
38628797	156	170	isoxazolidines	Chemical	-
38628797	174	179	RIPK1	Gene	8737
38628797	255	274	Alzheimer's disease	Disease	MESH:D000544
38628797	276	294	multiple sclerosis	Disease	MESH:D009103
38628797	300	329	amyotrophic lateral sclerosis	Disease	MESH:D000690
38628797	331	334	ALS	Disease	MESH:D000690
38628797	Association	MESH:D000690	8737
38628797	Association	MESH:D009103	8737
38628797	Association	MESH:D000544	8737

